Christopher W. Fulton

Array ( [id] => 5649669 [patent_doc_number] => 20060135404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Water soluble paclitaxel derivatives' [patent_app_type] => utility [patent_app_number] => 11/285392 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21842 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135404.pdf [firstpage_image] =>[orig_patent_app_number] => 11285392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880375 [patent_doc_number] => 20080153758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson\'s Disease' [patent_app_type] => utility [patent_app_number] => 11/719342 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7062 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153758.pdf [firstpage_image] =>[orig_patent_app_number] => 11719342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349931 [patent_doc_number] => 20090005292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Novel Peptides that Bind to the Erythropoietin Receptor' [patent_app_type] => utility [patent_app_number] => 11/718998 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 21946 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005292.pdf [firstpage_image] =>[orig_patent_app_number] => 11718998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296159 [patent_doc_number] => 07541430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Peptides for use in treating obesity' [patent_app_type] => utility [patent_app_number] => 11/268268 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19392 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541430.pdf [firstpage_image] =>[orig_patent_app_number] => 11268268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596829 [patent_doc_number] => 20060160747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Statine derivatives for the treatment of Alzheimer\'s disease II' [patent_app_type] => utility [patent_app_number] => 11/268429 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25625 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160747.pdf [firstpage_image] =>[orig_patent_app_number] => 11268429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652131 [patent_doc_number] => 20080039387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Novel Peptides for Use in the Treatment of Obesity' [patent_app_type] => utility [patent_app_number] => 11/666799 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17075 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039387.pdf [firstpage_image] =>[orig_patent_app_number] => 11666799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843369 [patent_doc_number] => 20060121553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Fluorogenic enzyme assay methods, kits and compositions using charge-balancers' [patent_app_type] => utility [patent_app_number] => 11/261173 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20881 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121553.pdf [firstpage_image] =>[orig_patent_app_number] => 11261173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913571 [patent_doc_number] => 20060128633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Colchinol derivatives as vascular damaging agents' [patent_app_type] => utility [patent_app_number] => 11/256018 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41029 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128633.pdf [firstpage_image] =>[orig_patent_app_number] => 11256018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939381 [patent_doc_number] => 20080076700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Method for the Preparation of Oxime, Thiazolidine, Dithiane, Dithiolane, or Hydrazone Linked Analogues of Growth Hormone' [patent_app_type] => utility [patent_app_number] => 11/577213 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7652 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076700.pdf [firstpage_image] =>[orig_patent_app_number] => 11577213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490814 [patent_doc_number] => 08030273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Protracted exendin-4 compounds' [patent_app_type] => utility [patent_app_number] => 11/664785 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10510 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030273.pdf [firstpage_image] =>[orig_patent_app_number] => 11664785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716304 [patent_doc_number] => 20060079667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Solid phase peptide synthesis of tri-peptide derivatives' [patent_app_type] => utility [patent_app_number] => 11/244624 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3064 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079667.pdf [firstpage_image] =>[orig_patent_app_number] => 11244624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814827 [patent_doc_number] => 20060084613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Inhibitors of the ICE/ced-3 family of cysteine proteases' [patent_app_type] => utility [patent_app_number] => 11/241857 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17027 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084613.pdf [firstpage_image] =>[orig_patent_app_number] => 11241857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743576 [patent_doc_number] => 20060089301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => '3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection' [patent_app_type] => utility [patent_app_number] => 11/241650 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19102 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089301.pdf [firstpage_image] =>[orig_patent_app_number] => 11241650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786473 [patent_doc_number] => 20060205672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/241656 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37451 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205672.pdf [firstpage_image] =>[orig_patent_app_number] => 11241656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439845 [patent_doc_number] => 07259273 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-21 [patent_title] => 'Compositions containing lysophosphotidic acids which inhabit apoptosis and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/236429 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 40921 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259273.pdf [firstpage_image] =>[orig_patent_app_number] => 11236429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4584898 [patent_doc_number] => 07851590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Y2 selective receptor agonists for therapeutic interventions' [patent_app_type] => utility [patent_app_number] => 12/067409 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11189 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851590.pdf [firstpage_image] =>[orig_patent_app_number] => 12067409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5826861 [patent_doc_number] => 20060062758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Tight junction modulator peptide PN159 for enhanced mucosal delivery of therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 11/233239 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062758.pdf [firstpage_image] =>[orig_patent_app_number] => 11233239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720729 [patent_doc_number] => 20060073504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Treatment of pain by inhibition of caspase signaling' [patent_app_type] => utility [patent_app_number] => 11/228424 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10809 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073504.pdf [firstpage_image] =>[orig_patent_app_number] => 11228424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748357 [patent_doc_number] => 20060111289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Compositions and methods of using Alpha-fetoprotein growth inhibitory peptides' [patent_app_type] => utility [patent_app_number] => 11/223610 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 32491 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111289.pdf [firstpage_image] =>[orig_patent_app_number] => 11223610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446955 [patent_doc_number] => 20090048181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/661060 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6509 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048181.pdf [firstpage_image] =>[orig_patent_app_number] => 11661060 [rel_patent_id] =>[rel_patent_doc_number] =>)